We’re building therapies for the patients current treatments leave behind.
At THERAtRAME, our mission is to develop transformative therapies for cancer patients left behind by existing treatments. We aim to:
- Reprogram tumor plasticity at its translational core
- Restore therapeutic vulnerability in immune-cold and resistant cancers
- Deliver first-in-class oral drugs with multi-indication potential
We are not building incremental improvements.
We are creating breakthrough medicines designed to redefine what is treatable in oncology.
We offer treatment options to patients.
Our Values
Scientific rigor. Pioneering innovation. Patient-first impact.
Scientific Excellence
Our foundation is built on over a decade of landmark research in tRNA biology and cancer. We translate cutting-edge science into actionable therapies.
Patient-Centric Impact
Every program is driven by unmet clinical need, targeting populations with limited or no therapeutic options.
Pioneering Innovation
We pursue novel mechanisms and unexplored biological spaces. We believe true breakthroughs require intellectual courage.
Rigor & Accountability
From discovery to clinical strategy, we operate with data-driven discipline and long-term value creation in mind.
Collaborative Vision
We engage openly with clinical leaders, regulatory experts, and pharma partners to accelerate responsible innovation.